Systematization of clinical trials related to treatment of metabolic syndrome, 1980-2015
Introduction Despite the clinical, epidemiological, and economic significance of metabolic syndrome, the profile of clinical trials on this disease is unknown. Objective To characterize the clinical trials related to treatment of metabolic syndrome during the 1980-2015 period. Methods Systematic rev...
- Autores:
-
Cardona Velásquez S.
Guzmán Vivares L.
Cardona Arias, Jaiberth Antonio
- Tipo de recurso:
- Article of journal
- Fecha de publicación:
- 2017
- Institución:
- Universidad Cooperativa de Colombia
- Repositorio:
- Repositorio UCC
- Idioma:
- OAI Identifier:
- oai:repository.ucc.edu.co:20.500.12494/41443
- Acceso en línea:
- https://doi.org/10.1016/j.jcms.2017.07.020
https://www.scopus.com/inward/record.uri?eid=2-s2.0-85061659561&doi=10.21071%2faz.v68i261.3944&partnerID=40&md5=b5d5253b5531dd59330d8042939cc419
https://hdl.handle.net/20.500.12494/41443
- Palabra clave:
- glucose
glycosylated hemoglobin
high density lipoprotein
placebo
triacylglycerol
Article
blood pressure
controlled clinical trial (topic)
diet
hip circumference
human
hyperglycemia
hypertension
hypertriglyceridemia
Italy
metabolic syndrome X
methodology
outcome assessment
physical activity
reproducibility
Spain
systematic review
United States
waist circumference
- Rights
- closedAccess
- License
- http://purl.org/coar/access_right/c_14cb
id |
COOPER2_337cb8edeacc433b6eaa5526aed66b78 |
---|---|
oai_identifier_str |
oai:repository.ucc.edu.co:20.500.12494/41443 |
network_acronym_str |
COOPER2 |
network_name_str |
Repositorio UCC |
repository_id_str |
|
spelling |
Cardona Velásquez S.Guzmán Vivares L.Cardona Arias, Jaiberth Antonio2021-12-16T22:15:31Z2021-12-16T22:15:31Z2017https://doi.org/10.1016/j.jcms.2017.07.020https://www.scopus.com/inward/record.uri?eid=2-s2.0-85061659561&doi=10.21071%2faz.v68i261.3944&partnerID=40&md5=b5d5253b5531dd59330d8042939cc41925300164https://hdl.handle.net/20.500.12494/41443Cardona S,Guzmán L,Cardona JA. Systematization of clinical trials related to treatment of metabolic syndrome, 1980-2015. Endocrinol Diabetes Nutr. 2017. 64. (2):p. 82-91. .Introduction Despite the clinical, epidemiological, and economic significance of metabolic syndrome, the profile of clinical trials on this disease is unknown. Objective To characterize the clinical trials related to treatment of metabolic syndrome during the 1980-2015 period. Methods Systematic review of the literature using an ex ante search protocol which followed the phases of the guide Preferred Reporting Items for Systematic Reviews and Meta-Analyses in four multidisciplinary databases with seven search strategies. Reproducibility and methodological quality of the studies were assessed. Results One hundred and six trials were included, most from the United States, Italy, and Spain, of which 63.2% evaluated interventions effective for several components of the syndrome such as diet (40.6%) or physical activity (22.6%). Other studies assessed drugs for a single factor such as hypertension (7.5%), hypertriglyceridemia (11.3%), or hyperglycemia (9.4%). Placebo was used as control in 54.7% of trials, and outcome measures included triglycerides (52.8%), HDL (48.1%), glucose (29.2%), BMI (33.0%), blood pressure (27.4%), waist circumference (26.4%), glycated hemoglobin (11.3%), and hip circumference (7.5%). Conclusion It was shown that studies ob efficacy of treatment for metabolic syndrome are scarce and have mainly been conducted in the last five years and in high-income countries. Trials on interventions that affect three or more factors and assess several outcome measures are few, and lifestyle interventions (diet and physical activity) are highlighted as most important to impact on this multifactorial syndrome. © 2017 SEEN0000-0002-7101-929Xjaiberth.cardona@campusucc.edu.co91-82Elsevier Doymaglucoseglycosylated hemoglobinhigh density lipoproteinplacebotriacylglycerolArticleblood pressurecontrolled clinical trial (topic)diethip circumferencehumanhyperglycemiahypertensionhypertriglyceridemiaItalymetabolic syndrome Xmethodologyoutcome assessmentphysical activityreproducibilitySpainsystematic reviewUnited Stateswaist circumferenceSystematization of clinical trials related to treatment of metabolic syndrome, 1980-2015Artículohttp://purl.org/coar/resource_type/c_6501http://purl.org/coar/resource_type/c_2df8fbb1http://purl.org/coar/version/c_970fb48d4fbd8a85info:eu-repo/semantics/articlehttp://purl.org/redcol/resource_type/ARTinfo:eu-repo/semantics/publishedVersionEndocrinologia, Diabetes Y Nutricioninfo:eu-repo/semantics/closedAccesshttp://purl.org/coar/access_right/c_14cbPublication20.500.12494/41443oai:repository.ucc.edu.co:20.500.12494/414432024-08-20 16:22:31.725metadata.onlyhttps://repository.ucc.edu.coRepositorio Institucional Universidad Cooperativa de Colombiabdigital@metabiblioteca.com |
dc.title.spa.fl_str_mv |
Systematization of clinical trials related to treatment of metabolic syndrome, 1980-2015 |
title |
Systematization of clinical trials related to treatment of metabolic syndrome, 1980-2015 |
spellingShingle |
Systematization of clinical trials related to treatment of metabolic syndrome, 1980-2015 glucose glycosylated hemoglobin high density lipoprotein placebo triacylglycerol Article blood pressure controlled clinical trial (topic) diet hip circumference human hyperglycemia hypertension hypertriglyceridemia Italy metabolic syndrome X methodology outcome assessment physical activity reproducibility Spain systematic review United States waist circumference |
title_short |
Systematization of clinical trials related to treatment of metabolic syndrome, 1980-2015 |
title_full |
Systematization of clinical trials related to treatment of metabolic syndrome, 1980-2015 |
title_fullStr |
Systematization of clinical trials related to treatment of metabolic syndrome, 1980-2015 |
title_full_unstemmed |
Systematization of clinical trials related to treatment of metabolic syndrome, 1980-2015 |
title_sort |
Systematization of clinical trials related to treatment of metabolic syndrome, 1980-2015 |
dc.creator.fl_str_mv |
Cardona Velásquez S. Guzmán Vivares L. Cardona Arias, Jaiberth Antonio |
dc.contributor.author.none.fl_str_mv |
Cardona Velásquez S. Guzmán Vivares L. Cardona Arias, Jaiberth Antonio |
dc.subject.spa.fl_str_mv |
glucose glycosylated hemoglobin high density lipoprotein placebo triacylglycerol Article blood pressure controlled clinical trial (topic) diet hip circumference human hyperglycemia hypertension hypertriglyceridemia Italy metabolic syndrome X methodology outcome assessment physical activity reproducibility Spain systematic review United States waist circumference |
topic |
glucose glycosylated hemoglobin high density lipoprotein placebo triacylglycerol Article blood pressure controlled clinical trial (topic) diet hip circumference human hyperglycemia hypertension hypertriglyceridemia Italy metabolic syndrome X methodology outcome assessment physical activity reproducibility Spain systematic review United States waist circumference |
description |
Introduction Despite the clinical, epidemiological, and economic significance of metabolic syndrome, the profile of clinical trials on this disease is unknown. Objective To characterize the clinical trials related to treatment of metabolic syndrome during the 1980-2015 period. Methods Systematic review of the literature using an ex ante search protocol which followed the phases of the guide Preferred Reporting Items for Systematic Reviews and Meta-Analyses in four multidisciplinary databases with seven search strategies. Reproducibility and methodological quality of the studies were assessed. Results One hundred and six trials were included, most from the United States, Italy, and Spain, of which 63.2% evaluated interventions effective for several components of the syndrome such as diet (40.6%) or physical activity (22.6%). Other studies assessed drugs for a single factor such as hypertension (7.5%), hypertriglyceridemia (11.3%), or hyperglycemia (9.4%). Placebo was used as control in 54.7% of trials, and outcome measures included triglycerides (52.8%), HDL (48.1%), glucose (29.2%), BMI (33.0%), blood pressure (27.4%), waist circumference (26.4%), glycated hemoglobin (11.3%), and hip circumference (7.5%). Conclusion It was shown that studies ob efficacy of treatment for metabolic syndrome are scarce and have mainly been conducted in the last five years and in high-income countries. Trials on interventions that affect three or more factors and assess several outcome measures are few, and lifestyle interventions (diet and physical activity) are highlighted as most important to impact on this multifactorial syndrome. © 2017 SEEN |
publishDate |
2017 |
dc.date.issued.none.fl_str_mv |
2017 |
dc.date.accessioned.none.fl_str_mv |
2021-12-16T22:15:31Z |
dc.date.available.none.fl_str_mv |
2021-12-16T22:15:31Z |
dc.type.none.fl_str_mv |
Artículo |
dc.type.coar.fl_str_mv |
http://purl.org/coar/resource_type/c_2df8fbb1 |
dc.type.coar.none.fl_str_mv |
http://purl.org/coar/resource_type/c_6501 |
dc.type.coarversion.none.fl_str_mv |
http://purl.org/coar/version/c_970fb48d4fbd8a85 |
dc.type.driver.none.fl_str_mv |
info:eu-repo/semantics/article |
dc.type.redcol.none.fl_str_mv |
http://purl.org/redcol/resource_type/ART |
dc.type.version.none.fl_str_mv |
info:eu-repo/semantics/publishedVersion |
format |
http://purl.org/coar/resource_type/c_6501 |
status_str |
publishedVersion |
dc.identifier.none.fl_str_mv |
https://doi.org/10.1016/j.jcms.2017.07.020 https://www.scopus.com/inward/record.uri?eid=2-s2.0-85061659561&doi=10.21071%2faz.v68i261.3944&partnerID=40&md5=b5d5253b5531dd59330d8042939cc419 |
dc.identifier.issn.spa.fl_str_mv |
25300164 |
dc.identifier.uri.none.fl_str_mv |
https://hdl.handle.net/20.500.12494/41443 |
dc.identifier.bibliographicCitation.spa.fl_str_mv |
Cardona S,Guzmán L,Cardona JA. Systematization of clinical trials related to treatment of metabolic syndrome, 1980-2015. Endocrinol Diabetes Nutr. 2017. 64. (2):p. 82-91. . |
url |
https://doi.org/10.1016/j.jcms.2017.07.020 https://www.scopus.com/inward/record.uri?eid=2-s2.0-85061659561&doi=10.21071%2faz.v68i261.3944&partnerID=40&md5=b5d5253b5531dd59330d8042939cc419 https://hdl.handle.net/20.500.12494/41443 |
identifier_str_mv |
25300164 Cardona S,Guzmán L,Cardona JA. Systematization of clinical trials related to treatment of metabolic syndrome, 1980-2015. Endocrinol Diabetes Nutr. 2017. 64. (2):p. 82-91. . |
dc.relation.ispartofjournal.spa.fl_str_mv |
Endocrinologia, Diabetes Y Nutricion |
dc.rights.accessrights.none.fl_str_mv |
info:eu-repo/semantics/closedAccess |
dc.rights.coar.none.fl_str_mv |
http://purl.org/coar/access_right/c_14cb |
eu_rights_str_mv |
closedAccess |
rights_invalid_str_mv |
http://purl.org/coar/access_right/c_14cb |
dc.format.extent.spa.fl_str_mv |
91-82 |
dc.publisher.spa.fl_str_mv |
Elsevier Doyma |
institution |
Universidad Cooperativa de Colombia |
repository.name.fl_str_mv |
Repositorio Institucional Universidad Cooperativa de Colombia |
repository.mail.fl_str_mv |
bdigital@metabiblioteca.com |
_version_ |
1814247261216964608 |